JP2002539224A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539224A5
JP2002539224A5 JP2000606063A JP2000606063A JP2002539224A5 JP 2002539224 A5 JP2002539224 A5 JP 2002539224A5 JP 2000606063 A JP2000606063 A JP 2000606063A JP 2000606063 A JP2000606063 A JP 2000606063A JP 2002539224 A5 JP2002539224 A5 JP 2002539224A5
Authority
JP
Japan
Prior art keywords
type
hcl
adenosine
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000606063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002539224A (ja
JP4949558B2 (ja
Filing date
Publication date
Priority claimed from AUPP9414A external-priority patent/AUPP941499A0/en
Priority claimed from AUPQ4199A external-priority patent/AUPQ419999A0/en
Application filed filed Critical
Priority claimed from PCT/AU2000/000226 external-priority patent/WO2000056145A1/en
Publication of JP2002539224A publication Critical patent/JP2002539224A/ja
Publication of JP2002539224A5 publication Critical patent/JP2002539224A5/ja
Application granted granted Critical
Publication of JP4949558B2 publication Critical patent/JP4949558B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000606063A 1999-03-23 2000-03-22 臓器の停止、保護、及び保存 Expired - Fee Related JP4949558B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
AU9414 1990-04-02
AUPP9414 1999-03-23
AUPP9414A AUPP941499A0 (en) 1999-03-23 1999-03-23 Organ arrest, protection and preservation
AUPQ4199A AUPQ419999A0 (en) 1999-11-23 1999-11-23 Organ arrest, protection and preservation
AU4199 1999-11-23
AUPQ4199 1999-11-23
PCT/AU2000/000226 WO2000056145A1 (en) 1999-03-23 2000-03-22 Organ arrest, protection and preservation

Publications (3)

Publication Number Publication Date
JP2002539224A JP2002539224A (ja) 2002-11-19
JP2002539224A5 true JP2002539224A5 (enExample) 2007-05-17
JP4949558B2 JP4949558B2 (ja) 2012-06-13

Family

ID=25646014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000606063A Expired - Fee Related JP4949558B2 (ja) 1999-03-23 2000-03-22 臓器の停止、保護、及び保存

Country Status (17)

Country Link
US (7) US6955814B1 (enExample)
EP (3) EP2359688B1 (enExample)
JP (1) JP4949558B2 (enExample)
KR (1) KR20020001797A (enExample)
CN (1) CN1344135A (enExample)
AT (1) ATE361667T1 (enExample)
BR (1) BR0010653A (enExample)
CA (1) CA2364687C (enExample)
DE (1) DE60034778T2 (enExample)
ES (1) ES2287001T3 (enExample)
IL (1) IL145552A0 (enExample)
MX (1) MXPA01009552A (enExample)
NO (2) NO331669B1 (enExample)
NZ (1) NZ514515A (enExample)
PL (1) PL351484A1 (enExample)
TR (1) TR200103235T2 (enExample)
WO (1) WO2000056145A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1344135A (zh) * 1999-03-23 2002-04-10 詹姆斯库克大学 器官的停止、保护和保存
CA2475209A1 (en) 2002-02-04 2003-08-14 Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda. Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
AUPS312602A0 (en) * 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
US20040170950A1 (en) * 2002-09-12 2004-09-02 Prien Samuel D. Organ preservation apparatus and methods
WO2004056180A1 (en) * 2002-12-23 2004-07-08 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery (1)
AU2003291847B2 (en) * 2002-12-23 2010-12-02 Hibernation Therapeutics, A Kf Llc Organ preconditioning, arrest, protection, preservation and recovery
AU2007234006A1 (en) * 2006-03-31 2007-10-11 Adenobio N.V. Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
CN104107431A (zh) * 2006-05-29 2014-10-22 低温药理有限公司 改善的组织维持
JP2009538834A (ja) * 2006-05-29 2009-11-12 ハイバーネイション セラピューティクス リミテッド 組織維持の改善
US7811549B2 (en) * 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
SG173404A1 (en) * 2006-07-25 2011-08-29 Hibernation Therapeutics Ltd Trauma therapy
CA2717162A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
WO2008134740A1 (en) * 2007-04-30 2008-11-06 The Trustees Of The University Of Pennsylvania System and method of resuscitation of a mammal
EP2219442A4 (en) * 2007-07-25 2012-05-02 Hibernation Therapeutics Ltd IMPROVED ORGAN PROTECTION, IMPROVED ORGAN CONSERVATION AND IMPROVED ORGAN RECOVERY
DE102007035642A1 (de) * 2007-07-30 2009-02-12 Grietje Beck Substanzen zur Protektion von Zellen und Geweben gegen Schädigung durch ungünstige Bedingungen
US20090185973A1 (en) * 2008-01-22 2009-07-23 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
US20120046354A1 (en) * 2010-08-18 2012-02-23 Ehrenpreis Eli D Anti-oxidant lozenges for the prevention and treatment of radiation induced mucositis, precancerous lesions, oral cancer and other oral cavity mucosal disorders
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
EP2908858B1 (en) 2012-10-19 2020-06-24 New York University Compositions for use in inhibiting osteolysis
EP3021856B1 (en) 2013-07-17 2020-10-07 Hibernation Therapeutics, a KF LLC Composition for inducing organ arrest and protection, preservation and reduction of tissue injury
JP2013234200A (ja) * 2013-08-19 2013-11-21 Hibernation Therapeutics Ltd 組織維持の改善
US10092591B2 (en) 2014-02-27 2018-10-09 University Of Alaska Fairbanks Methods and compositions for the treatment of ischemic injury to tissue using therapeutic hypothermia
CN103893205B (zh) * 2014-04-15 2016-03-09 青岛大学附属医院 一种包含利多卡因和腺苷的心脏停搏液及其制备方法
US20170049811A1 (en) * 2014-05-01 2017-02-23 Catherine E. Berry Modified single dose, microplegic approach to cardioplegia for adult heart
US9501418B2 (en) * 2014-06-26 2016-11-22 HGST Netherlands B.V. Invalidation data area for cache
US9913903B2 (en) * 2015-08-06 2018-03-13 Grifols Worldwide Operations Limited Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM
CN109769797B (zh) * 2017-11-13 2024-09-10 合肥华琪生物工程有限公司 一种器官保存液
US12471592B2 (en) 2021-08-18 2025-11-18 Reelabs Private Limited Cytoprotective compositions for short-term cells storage and transportation without cryopreservation and deep freezing

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU878297A1 (ru) 1978-05-03 1981-11-07 Научно-Исследовательский Институт Трансплантологии И Искусственных Органов Состав дл сохранени жизнеспособности оперируемого сердца
US4798824A (en) * 1985-10-03 1989-01-17 Wisconsin Alumni Research Foundation Perfusate for the preservation of organs
US5006512A (en) 1987-10-02 1991-04-09 Tsuyoshi Ohnishi Therapeutic usages of inhibitors for a potassium efflux channel
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
DE3926287A1 (de) * 1989-08-09 1991-02-21 Bernhard Clasbrummel Medizinische anwendung von omega-conotoxin gvia oder omega-conotoxin gvia-analoga zur sympathikolyse
US5145771A (en) 1990-04-12 1992-09-08 The University Of North Carolina At Chapel Hill Rinse solution for organs and tissues
US5206222A (en) 1991-05-22 1993-04-27 Vanderbilt University Methods for the reduction of myocardial reperfusion injury
CN1057192A (zh) 1991-06-30 1991-12-25 汪庆富 风油精聚胺酯海绵的制备工艺
US5407793A (en) 1991-10-18 1995-04-18 University Of Pittsburgh Of The Commonwealth System Of Higher Education An aqueous heart preservation and cardioplegia solution
RU2025973C1 (ru) * 1992-02-10 1995-01-09 Научно-производственное предприятие "Биофарм" Раствор для консервации живых органов
US5370989A (en) 1992-04-03 1994-12-06 The Trustees Of Columbia University In The City Of New York Solution for prolonged organ preservation
US5405742A (en) * 1993-07-16 1995-04-11 Cyromedical Sciences, Inc. Solutions for tissue preservation and bloodless surgery and methods using same
US5679706A (en) * 1994-09-30 1997-10-21 Bristol-Myers Squibb Company Combination of a potassium channel activator and an antiarrhythmic agent
US5554497A (en) * 1994-12-12 1996-09-10 Charlotte-Mecklenburg Hospital Authority Cardioplegic solution for arresting an organ
US5656420A (en) * 1995-02-24 1997-08-12 University Of Kentucky Research Foundation Method for employing the delta opioid dadle to extend tissue survival time during ischemia
JP3875295B2 (ja) * 1995-11-30 2007-01-31 功 竹内 心筋保護液
US6043224A (en) 1996-09-05 2000-03-28 The Massachusetts Institute Of Technology Compositions and methods for treatment of neurological disorders and neurodegenerative diseases
IT1297886B1 (it) * 1997-02-28 1999-12-20 Carmine Antropoli Nifedipina per uso topico
CA2295195C (en) * 1997-06-18 2009-12-15 Discovery Therapeutics, Inc. Compositions and methods for preventing restenosis following revascularization procedures
CN1057192C (zh) 1997-09-10 2000-10-11 上海长征医院 一种配制多器官保存液的方法
US6011017A (en) 1998-04-15 2000-01-04 Cypros Pharmaceutical Corp. Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass
US7700122B1 (en) 1998-07-16 2010-04-20 Memorial Sloan-Kettering Cancer Center Topical compositions comprising an opioid analgesic and an NMDA antagonist
KR100269540B1 (ko) 1998-08-28 2000-10-16 윤종용 웨이퍼 상태에서의 칩 스케일 패키지 제조 방법
EP1041970B1 (en) 1998-10-23 2013-07-03 Polyheal Ltd. Compositions of microspheres for wound healing
US6358208B1 (en) 1998-11-21 2002-03-19 Philipp Lang Assessment of cardiovascular performance using ultrasound methods and devices that interrogate interstitial fluid
CN1344135A (zh) 1999-03-23 2002-04-10 詹姆斯库克大学 器官的停止、保护和保存
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
WO2001054679A2 (en) 2000-01-27 2001-08-02 Children's Hospital Research Foundation Transdermal composition containing an anesthetic and a vasodilator agent
JP2001261575A (ja) 2000-03-13 2001-09-26 General Hospital Corp 血管収縮を調節する方法とその組成物
US6569615B1 (en) 2000-04-10 2003-05-27 The United States Of America As Represented By The Department Of Veteran's Affairs Composition and methods for tissue preservation
JP2004512260A (ja) 2000-04-28 2004-04-22 メモリアル　スローン−ケッタリング　キャンサー　センター 局所麻酔／オピオイド製剤およびその使用方法
WO2002026140A1 (en) 2000-09-26 2002-04-04 Medtronic, Inc. Medical method and system for directing blood flow
GB0028414D0 (en) 2000-11-22 2001-01-03 Univ Leeds Flush preservation solution
EP1478660A4 (en) 2002-01-29 2005-02-09 Cognetix Inc KAPPA-PVIIA-RELATED CONOTOXINS AS ORGAN PROTECTIVE AGENTS
RU2332220C2 (ru) 2002-04-18 2008-08-27 Си Ви Терапьютикс, Инк. Способ снижения частоты сердечных сокращений, включающий введение агониста рецептора аденозина а1 вместе с бета-блокатором, блокатором кальциевых каналов или сердечным гликозидом
AUPS312602A0 (en) 2002-06-21 2002-07-18 James Cook University Organ arrest, protection, preservation and recovery
US20040229780A1 (en) * 2002-09-20 2004-11-18 Olivera Baldomero M. KappaM-conopeptides as organ protectants
US6921633B2 (en) 2002-11-18 2005-07-26 Biolife Solutions Incorporated Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
US20040167226A1 (en) 2002-12-16 2004-08-26 Serafini Tito A. Methods for the treatment of pain and traumatic injury using benzamides and compositions containing the same
WO2004056180A1 (en) 2002-12-23 2004-07-08 Global Cardiac Solutions Pty Ltd Organ preconditioning, arrest, protection, preservation and recovery (1)
GB2436255B (en) 2002-12-23 2007-11-28 Global Cardiac Solutions Pty L Organ preconditioning, arrest, protection, preservation and recovery
US6992075B2 (en) 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
JP2006526634A (ja) 2003-06-02 2006-11-24 サマリタン，ファーマスーティカルス，インク． 神経保護作用を有するベンゾアート化合物およびベンズアミド化合物
US7049309B2 (en) * 2003-10-14 2006-05-23 Bristol-Myers Squibb Company 3-Thia-4-arylquinolin-2-one potassium channel modulators
JP2008525468A (ja) 2004-12-22 2008-07-17 エモリー・ユニバーシティ ポストコンディショニング臓器保護作用を増強する治療補助薬
WO2007030198A2 (en) 2005-07-11 2007-03-15 Human Biosystems Improved methods and solutions for storing donor organs
JP2009538834A (ja) 2006-05-29 2009-11-12 ハイバーネイション セラピューティクス リミテッド 組織維持の改善
SG173404A1 (en) 2006-07-25 2011-08-29 Hibernation Therapeutics Ltd Trauma therapy
CA2717162A1 (en) 2007-03-02 2008-09-12 Hibernation Therapeutics Limited Transplants
CN100423638C (zh) 2007-03-22 2008-10-08 南京吉脉生物技术有限公司 一种器官保存液及其制备方法
EP2219442A4 (en) 2007-07-25 2012-05-02 Hibernation Therapeutics Ltd IMPROVED ORGAN PROTECTION, IMPROVED ORGAN CONSERVATION AND IMPROVED ORGAN RECOVERY

Similar Documents

Publication Publication Date Title
JP2002539224A5 (enExample)
ES2316575T3 (es) Derivado de fenilpiridincarbonilpiperazina.
JP2003518475A5 (enExample)
ES2435191T3 (es) Agentes antiparasitarios
JP2005513123A5 (enExample)
TWI351401B (en) Morpholinyl containing benzimidazoles as inhibitor
HUP0201659A2 (hu) Kristályos benzimidazol-vegyület
RU2006113638A (ru) Антагонисты рецептора тромбина
EE200300586A (et) Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks
CA2487365A1 (en) Piperidine derivatives as potassium channel blockers
GB0324654D0 (en) Medicinal compounds
EP0355583B1 (en) Cardiotonics
JP2003531118A5 (enExample)
HRP20080226T3 (en) Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
YU88901A (sh) Derivati purina
NO20066041L (no) Anvendelse av substituerte kinolinderivater for behandlingen og legemiddelresistente mykobakterielle sykdommer
AR040021A1 (es) (s)-4-amino-5-cloro-2-metoxi-n-[1-[1-(2-tetrahidrofuril-carbonil)-4-piperidinilmetil]-4-piperidinil]benzamida, procedimiento para su preparacion, composicion farmaceutica que la contiene, e intermediarios para su preparacion
NO20034311L (no) CCR5-antagonister for behandling av AIDS
JP2011524896A5 (enExample)
WO2004094418A8 (en) Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
JP2002508358A5 (enExample)
KR870003995A (ko) 신규 화합물의 제조방법
MY130927A (en) Anhydrous crystalline 1-(4(s)-azido-2(s), 3(r)-dihydroxy-4-(hydroxymethyl)-1(r)-cyclopentyl)cytosine hemisulfate as useful as an antiviral agent
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
DE60213087D1 (de) Pyrimidin-derivate als selektive inhibitoren von cox-2